Points to consider:
- Do you have a target, pathway and the ability to modulate these?
- Do you have any evidence that your target is clinically relevant e.g. evidence from GWAS studies or evidence of mutations that cause a human phenotype?
- Have potential toxicity issues been considered?
If you are unsure whether your research is at this stage or if you require funding to get to this stage, please contact a member of the team to discuss at firstname.lastname@example.org.